Coopers Animal Health Australia Ltd v Western Stock Distributors Pty Ltd

Coopers Animal Health Australia Ltd sought to enforce a petty patent for a sheep lousicide against Western Stock Distributors Pty Ltd, which was challenged on the basis of invalidity. The dispute was adjudicated by the Federal Court of Australia. The primary issues before the Court were the validity of the patent, focusing on the priority date, whether the claims of the patent were fairly based on earlier specifications, and the novelty, obviousness, and utility of the claimed invention.

The Court examined whether the petty patent was preceded by a provisional specification, a complete specification, and an amended complete specification, and if the claims were fairly based on any of these earlier documents. The significance of the priority date was also considered in relation to the novelty of the invention. Furthermore, the Court assessed whether the invention had been disclosed by the patent for a pour-on formulation for the control of other insects and whether the disclosure in trials of the respondent's product rendered the patent obvious. Expert opinions were evaluated alongside the history of the product's development. Lastly, the utility of the claimed invention was scrutinised, particularly the inclusion of pyrethroids which were not deemed useful and the lack of specification of the appropriate dose and the entire solvent formula.

The Court found that the petty patent was invalid, as it was not fairly based on any of the earlier specifications, and the priority date did not provide the necessary novelty to the claims. The patent failed to demonstrate that the invention was not obvious at the time, given the prior art and the history of the product's development. Additionally, the claimed invention lacked utility due to the inclusion of ineffective ingredients and the absence of a specified appropriate dose and complete solvent formula. Consequently, the Court dismissed the application, declared the petty patent invalid, and ordered that the applicant pay the respondents' costs. Leave was reserved for the respondent to apply for revocation of the patent under section 103 of the Patents Act 1952.